MEDIROM Healthcare Technologies EBITDA 2021-2024 | MRM

MEDIROM Healthcare Technologies ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
MEDIROM Healthcare Technologies Annual EBITDA
(Millions of US $)
2024 $2
2023 $-1
2022 $2
2021 $-3
2020 $-6
2019 $0
MEDIROM Healthcare Technologies Quarterly EBITDA
(Millions of US $)
2024-12-31
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.056B $0.055B
MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.101B 19.20
Encompass Health (EHC) United States $12.447B 24.86
DaVita (DVA) United States $9.836B 14.06
Elanco Animal Health (ELAN) United States $9.186B 20.54
Chemed (CHE) United States $6.635B 22.22
RadNet (RDNT) United States $5.483B 198.03
Option Care Health (OPCH) United States $4.640B 19.85
LifeStance Health (LFST) United States $2.135B 0.00
Addus HomeCare (ADUS) United States $2.126B 22.92
Astrana Health (ASTH) United States $1.750B 61.20
Aveanna Healthcare Holdings (AVAH) United States $1.640B 30.19
U.S Physical Therapy (USPH) United States $1.286B 32.17
Atai Life Sciences (ATAI) Germany $0.980B 0.00
Pennant (PNTG) United States $0.846B 29.87
Daxor (DXR) United States $0.055B 0.00
Psychemedics (PMD) United States $0.000B 0.00